Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer

NCT00536809 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Colorectal

Interventions

DRUG: lapatinib
DRUG: oxaliplatin
DRUG: capecitabine

Sponsor

GlaxoSmithKline